Understood and fair point, however st same time having them on register is disincentive to other potential acquirors given their defacto control; unattractive to private equity, other major healthcare groups both local and importantly international players that want immediate footprint expansion. In addition, don't discount soft influence on strategic execution by PRY that may exist to detriment of other shareholders ie. not being supportive of broadening service offerings into areas that PRY competes etc.
VEI Price at posting:
71.5¢ Sentiment: None Disclosure: Not Held